Abstract

Purpose: A new flow cytometric technique that allows for two incorporated thymidine analogues to be measured simultaneously and independently has been used to improve the accuracy of in vivo cell kinetic estimates, i.e., the length of S-phase (TS) and potential doubling time ( T pot). Methods and Materials: The analogues chlorodeoxyuridine and iododeoxyuridine were injected at different times into mice bearing the mouse mammary tumor MCaK. At different times after labeling, the tumors were harvested and prepared for three color flow cytometric analysis of DNA, chlorodeoxyuridine, and iododeoxyuridine. Control experiments showed that similar estimates of T pot were obtained from each label when administered singly, or as staggered pulses. Comparisons were made between T s and T pot calculated from a single label (single point), from the averaged result of the two labels from the same tumor (two point-ave), and from the simultaneous nonlinear fitting of the measured parameters from the two labels, from the same tumor (two point-fit). These estimates of T s and T pot were then compared to reference values obtained by fitting the pooled measured parameters from all the tumors, that were labeled for different periods of time. Results: While all of the methods resulted in similar mean estimates of T s and T pot that were close to the reference values, the fewest assumptions, and the least variability in the results, were obtained using the two point-fit data. Conclusion: The estimation of T pot using two thymidine analogues is more accurate than that obtained from a single label.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.